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Abstract
Introduction Extensive mammographic density in women is
associated with increased risk for breast cancer. Mouse models
provide a powerful approach to the study of human diseases,
but there is currently no model that is suited to the study of
mammographic density.
Methods We performed individual manipulations of the stromal,
epithelial and matrix components of the mouse mammary gland
and examined the alterations using in vivo and ex vivo radiology,
whole mount staining and histology.
Results Areas of density were generated that resembled
densities in mammographic images of the human breast, and the
nature of the imposed changes was confirmed at the cellular
level. Furthermore, two genetic models, one deficient in
epithelial structure (Pten conditional tissue specific knockout)
and one with hyperplastic epithelium and mammary tumors
(MMTV-PyMT), were used to examine radiographic density.
Conclusion Our data show the feasibility of altering and
imaging mouse mammary gland radiographic density by
experimental and genetic means, providing the first step toward
modelling the biological processes that are responsible for
mammographic density in the mouse.
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Introduction
The radiological appearance of the breast on mammogra-
phy varies greatly among women because of the different
X-ray attenuation characteristics of fat, and epithelial and
stromal components that comprise the breast tissue [1,2].
A method of classifying these variations was described by
Wolfe in 1976 [3], and extensive mammographic density is
now recognized to be one of the most important risk factors
for human breast cancer [4-13]. Women with mammo-
graphic density in more than 75% of breast tissue are at
four to six times higher risk for developing breast cancer
than those with little or no density [5,10,14]. Although the
elements that constitute mammographic density are poorly
understood at present, there is evidence that stromal and
epithelial cells, as well as collagen, contribute toward den-
sity in human mammographic images [15-17].
Disease modelling in mice has become a powerful tool for
investigating the physiological and genetic factors that are
involved in human disease. It is not known whether mam-
mary gland density is a risk factor in mice because a suita-
ble mouse model in which to study mammary density is
currently lacking. As a necessary first step toward the even-
tual goal of developing such a mouse model, here we asked
whether mammographic density could be altered within the
mouse mammary gland. In particular, we designed our
study to evaluate whether experimental manipulation of
individual compartments, namely the stromal cells, matrix,
or epithelium, leads to altered radiological mammographic
density. We also took a genetic approach to address the
correlation between epithelial structure and mammo-
graphic density using genetically engineered mouse
mutants.
Methods
The fourth inguinal mammary glands were selected for the
study because they contain a centrally located lymph node
that can guide the site of inoculation, and because theyBreast Cancer Research    Vol 6 No 5    Hariri et al.
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have been widely studied [18-20]. Injections were always
performed frontal to the lymph node. The contralateral
inguinal mammary gland in each mouse was used as the
sham control. Inoculations included a 40 µl volume of either
Matrigel (Becton Dickinson, Mississauga, Ontario, Can-
ada) or cell media containing 5 × 106 Swiss 3T3 fibrob-
lasts. Mammary glands following experimental
manipulations or sham (surgery followed by the needle
insertion) were isolated 5 days later. For ex vivo imaging
studies, each gland was successively subjected to the fol-
lowing regimen: immediate radiography using Faxitron
Specimen Radiography System (Model MX-20; 5 s expo-
sure time at 18 kV; Faxitron X-Ray Corp., Wheeling, Illinois,
USA) on the tissue placed in a plastic petri dish; whole
mount carmine alum staining upon mounting the tissue on
a glass slide using standard protocols [19]; and histology
following tissue fixation and paraffin embedding.
For  in vivo imaging studies, 5 days after experimental
manipulations x-ray images of anaesthetized mice were
taken using Faxitron Specimen Radiography System
(Model MX-20; 10 s exposure time at 24 kV). The unin-
jected contralateral glands served as controls. Mammary
glands were positioned flat using 25 G needles. Mammary
glands were then Isolated and imaged ex vivo.
All purchased mice were females from The Jackson Labo-
ratory (Bar Harbor, Maine, USA). Strains used were: a)
FVB/N, and b) BALB/c Foxn1nu/Foxn1nu nude mice, c)
MMTV-PyMT transgenic on FVB/N background, and d)
Pten-deficient mice were in a mixed background of C57BL/
6 and 129SvEvTac strain, in these mice inactivation of Pten
has been achieved in several organs including breast using
the Cre-loxP system (PtenloxP/loxP; Mmtv-cre mice) [21,22].
The epithelial ductal tree is severely stunted in these mice
and serves as a model of epithelial hypoplasia. The animals
were cared for in accordance with the guidelines estab-
lished by the Canadian Council on Animal Care.
Results and discussion
As illustrated, sham treated mammary glands produced a
homogeneous radiological image (Fig. 1a), and the mam-
mary whole mount (Fig. 1b) indicated little intragland varia-
tion. Histology showed an epithelial ductal tree emanating
from the teat region (arrowhead), spanning the mammary
fat pad (Fig. 1c) and embedded within the adipose com-
partment (arrowheads in Fig. 1d). Trichrome-stained tissue
(Fig. 1e) showed ductal epithelium composed of a single
layer of epithelial cells (arrowhead) surrounded by stromal
fibroblasts (arrow) that lay within the extracellular matrix
(blue staining). Next, we undertook to alter these specific
components of the mammary tissue.
Matrigel, which is basement membrane matrix derived from
Engelbreth-Holm-Swarm mouse sarcoma, and is com-
posed mostly of laminin, collagen type IV, heparan sulphate
proteoglycans, entactin and nidogen, was administered to
produce local matrix deposition. When examined 5 days
later by radiology, the Matrigel injected site was evident as
a pronounced radiologically dense area (arrowheads in Fig.
1f), which was also apparent in the whole mount (arrow-
heads in Fig. 1g). Trichrome staining of mammary tissue
sections confirmed the presence of collagens embedded
within the mammary fat pad at this particular location
(arrowheads in Fig. 1h). Higher magnification images
showed collagen surrounding clusters of cells (Fig. 1i,1j).
Next, we reasoned that fibroblasts would provide a means
of increasing the stromal cell component of the mammary
gland. Figure 1k shows the radiological image following an
inoculation of Swiss 3T3 fibroblasts. A highly dense pocket
was evident in the mammographic radiograph (arrow-
heads), and a cellular mass could be seen frontal to the
lymph node in the whole mount (Fig. 1l) and histology (Fig.
1m), as highlighted by the arrowheads. Fibroblasts (arrow-
heads) were the major cellular component of this mass,
with some infiltration by polymorphonuclear cells (arrows)
that probably represented a limited inflammatory response
(Fig. 1n,1o).
Finally, for manipulation of the epithelial compartment,
mammary glands were taken from pregnant mice at day 13
of gestation. During pregnancy, alveolar epithelial cells pro-
liferate and differentiate to become secretory alveoli in
preparation for lactation, replacing much of the adipose
compartment such that the mammary gland is primarily
comprised of epithelial structures [23-25]. Radiology
revealed a smattering of density dispersed throughout the
gland, with most densities nearest to the lymph node, and
gradually fading toward the edges of the gland (Fig. 1p).
This density mirrored the epithelial ductal tree at the whole
mount level (Fig. 1q), and an abundance of lobuloalveoli
was evident at the cellular level (Fig. 1r,1s,1t). All of the
above observations were reproduced in at least three inde-
pendent experiments.
Having found that expanded epithelial structures formed
during gestation correlated with increased mammographic
density, we next examined whether mammary gland with
hypoplastic epithelium would exhibit reduced radiographic
density. Seven-week-old Pten conditional knockout mice,
which have severely attenuated ductal epithelium (Fig.
2f,2g,2h,2i,2j), and their age-matched wild-type littermates
(Fig. 2a,2b,2c,2d,2e) were examined. At this age, the epi-
thelial ductal tree typically grows past the lymph node in
wild-type mice, covering two-thirds of the mammary fat pad
(Fig. 2b). A reduction in density was noticeable in the
mouse mammographic images of Pten-deficient mice as
compared with control animals (Fig. 2f versus Fig. 2a).
Whole mounts (Fig. 2g versus Fig. 2b) and histology (Fig.Available online http://breast-cancer-research.com/content/6/5/R540
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Figure 1
Generation of mammographic densities in the mouse mammary gland Generation of mammographic densities in the mouse mammary gland. Panels a–e represent a mammary gland from sham treated mice, f–j illustrate 
Matrigel injected mammary glands, k–o show fibroblast inoculated mammary gland, and p–t show a mammary gland from a pregnant mouse at day 
13 of gestation. Each set of glands was successively analyzed by radiography (panels a, f, k and p), carmine alum whole mount staining (panels b, g, 
l and q), and trichrome staining (panels c–e, h–j and m–o) or haematoxylin and eosin staining (panels r–t). The size bar in panel c is 2 mm, and this 
magnification also applies to panels a, b, f–h, k–m and p–r. The size bar in panel d is 0.2 mm (which also applies to panels i and n); in panel e it is 20 
µm; in panel j it is 0.04 mm (which also applies to panel t); in panel o it is 10 µm; and in panel s it is 1 mm. LN, lymph node.Breast Cancer Research    Vol 6 No 5    Hariri et al.
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2h versus Fig. 2c) of Pten-deficient mice exhibited an
absence of epithelial and stromal structures. Lymphomas
are prevalent in these mutant animals by 6 weeks of age
[22], and are noticeable in Fig. 2.
Next we generated and imaged mammographic density in
intact mammary glands in vivo. In order to avoid any poten-
tial interference from the hair coat on radiographic imaging,
we chose to use nude mice in our initial in vivo experiments.
Radiographic imaging was performed 5 days after injection
of either matrigel or fibroblasts, or at day 14 of gestation
(Fig. 3c,3d,3e,3f,3g,3h). Mice were anaesthetized, and the
fourth mammary gland was flattened by pinning. Figure 3a
and 3b show a representative unmanipulated mammary
gland with homogeneous radiographic density. The mar-
gins of the mammary gland are demarcated by yellow dot-
ted lines, and the lymph nodes are indicated. Injected cells
and matrigel created a region of density (arrowheads) dis-
tinguishable from the surrounding normal gland (Fig. 3c,3f).
Such regions were not present in any of the untreated con-
tralateral glands, which served as controls for each mouse
(Fig. 3a,3b). Increased density was also apparent in the
mammary gland of a mouse at day 14 of gestation, but was
less well demarcated because of its diffuse nature (Fig.
3g,3h). Ex vivo radiography of all of these glands confirmed
the presence of density observed in vivo (Fig.
3b,3d,3f,3h,3j).
Using a well established mammary tumor model, the
MMTV-PyMT mouse, we next imaged the hyperplastic and
tumor bearing mammary gland by radiography in an intact
80-day-old mouse. Figure 3i and 3j illustrate the highly
increased in vivo and  ex vivo radiographic density that
results from mammary tumor formation.
Figure 2
Mouse mammographic images of PtenloxP/loxP; Mmtv-cre mice Mouse mammographic images of PtenloxP/loxP; Mmtv-cre mice. (a–e) Wild-type littermates or (f–j) mammary gland-specific pten deficient mice were 
successively subjected to radiography (panels a and f), carmine alum whole mount staining (panels b and g) and haematoxylin and eosin staining 
(panels c and h). Higher magnification of the mammary tissue (panels d, e, I and j) are shown. The size bar in panel c is 2 mm, and this magnification 
also applies to panels a, b and f–h. The size bar in panel d is 1 mm; in panel e it is 0.2 mm (which also applies to panel i); and in panel j it is 0.04 mm. 
LN, lymph node.Available online http://breast-cancer-research.com/content/6/5/R540
R544
Conclusion
This study establishes the mouse as a model for mammo-
graphic density research and demonstrates the feasibility
of mouse mammographic imaging. Here we show for the
first time that mouse mammography can be carried out in
vivo. Furthermore, we demonstrate that mammographic
density can be experimentally induced and imaged in a live
mouse. Areas of density were generated experimentally
through individual manipulation of stromal fibroblasts, epi-
thelium, or matrix, which produced qualitatively distinct
mammographic images both in vivo and ex vivo. Further-
more,  Pten-deficient mice and MMTV-PyMT transgenic
mice served as genetic models in which to investigate
whether the inherent structure of mammary gland corre-
lates with mammographic density. The hypoplastic epithe-
lium in Pten-deficient mice resulted i n  g l a n d s  w i t h  l o w
mammographic density and, conversely, hyperplastic
glands of MMTV-PyMT exhibited pronounced radiographic
density.
This new line of research faces many challenges. One of
these is the need to maintain experimentally generated
Figure 3
In vivo and ex vivo images of normal and altered mammographic density In vivo and ex vivo images of normal and altered mammographic density. Panels a, c, e, g and i are mammographic images from live mice, and pan-
els b, d, f, h and j are the same glands imaged ex vivo. Mice were treated as follows: panels a and b, untreated mouse; panels c and d, mammary 
gland inoculated with fibroblasts; panels e and f, mammary gland injected with matrigel; and panels g and h, day 14 of gestation. Panels I and j are 
from an MMTV-PyMT mouse with multiple mammary tumors. The size bar in all panels is 5 mm. LN, lymph node.Breast Cancer Research    Vol 6 No 5    Hariri et al.
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mammographic density over a tim e  p e r i o d  t h a t  i s  s u f f i -
ciently prolonged to allow development of the
pathophysiological changes that lead to mammary cancer
in mice. Comparisons between highly dense and less
dense mammary glands may reveal differences in their sus-
ceptibility to mammary tumor formation. There is also a
need to quantify and standardize mouse mammograms
accurately, using means such as those developed for
human mammography [26-28]. This will allow research on
mammographic density using genetic mouse models that
have either a loss-of-function or gain-of-function of genes
linked to breast cancer. Specifically, it will help us to
explore the relationship between genetic changes, mam-
mographic density and breast cancer susceptibility. This
work forms the basis for exploiting the mouse as a model in
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